Companies House 08365466 2025-01-31 2025-01-31 2024-02-01 false iso4217:GBP xbrli:pure 08365466 2023-02-01 2024-01-31 08365466 2025-01-31 08365466 2024-02-01 2025-01-31 08365466 2024-01-31 08365466 curr:PoundSterling 2024-02-01 2025-01-31 08365466 uk-bus:CompanyLimitedByGuarantee 2024-02-01 2025-01-31 08365466 uk-bus:FRS102 2024-02-01 2025-01-31 08365466 uk-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 08365466 uk-bus:FullAccounts 2024-02-01 2025-01-31 08365466 uk-bus:RegisteredOffice 2024-02-01 2025-01-31 08365466 uk-bus:Director1 2024-02-01 2025-01-31 08365466 uk-bus:Director2 2024-02-01 2025-01-31 08365466 uk-bus:Director3 2024-02-01 2025-01-31 08365466 uk-bus:Director4 2024-02-01 2025-01-31 08365466 uk-bus:Director5 2024-02-01 2025-01-31 08365466 uk-bus:Director6 2024-02-01 2025-01-31 08365466 uk-bus:Director7 2024-02-01 2025-01-31 08365466 uk-bus:Director8 2024-02-01 2025-01-31 08365466 uk-bus:Director9 2024-02-01 2025-01-31 08365466 uk-bus:Director10 2024-02-01 2025-01-31 08365466 uk-bus:Director11 2024-02-01 2025-01-31 08365466 uk-bus:Director12 2024-02-01 2025-01-31 08365466 uk-bus:Director13 2024-02-01 2025-01-31 08365466 uk-bus:Director14 2024-02-01 2025-01-31 08365466 uk-bus:Director15 2024-02-01 2025-01-31 08365466 uk-bus:Director16 2024-02-01 2025-01-31 08365466 uk-bus:Director17 2024-02-01 2025-01-31 08365466 uk-bus:Director18 2024-02-01 2025-01-31 08365466 uk-bus:Director19 2024-02-01 2025-01-31 08365466 uk-bus:Director20 2024-02-01 2025-01-31 08365466 uk-bus:Director21 2024-02-01 2025-01-31 08365466 uk-bus:CompanySecretary1 2024-02-01 2025-01-31 08365466 core:AfterOneYear 2025-01-31 08365466 core:AfterOneYear 2024-01-31 08365466 core:WithinOneYear 2025-01-31 08365466 core:WithinOneYear 2024-01-31 08365466 core:WithinOneYear 2024-02-01 2025-01-31 08365466 core:AfterOneYear 2025-01-31 08365466 core:AfterOneYear 2024-01-31 08365466 core:AfterOneYear 2024-02-01 2025-01-31 08365466 core:ShareCapital 2025-01-31 08365466 core:ShareCapital 2024-01-31 08365466 core:SharePremium 2025-01-31 08365466 core:SharePremium 2024-01-31 08365466 core:OtherReservesSubtotal 2025-01-31 08365466 core:OtherReservesSubtotal 2024-01-31 08365466 core:RevaluationReserve 2025-01-31 08365466 core:RevaluationReserve 2024-01-31 08365466 core:RetainedEarningsAccumulatedLosses 2025-01-31 08365466 core:RetainedEarningsAccumulatedLosses 2024-01-31 08365466 1 2024-02-01 2025-01-31 08365466 2 2024-02-01 2025-01-31 08365466 3 2024-02-01 2025-01-31 08365466 core:LandBuildings 2024-02-01 2025-01-31 08365466 core:LandBuildings 2025-01-31 08365466 core:LandBuildings 2023-02-01 2024-01-31 08365466 core:LandBuildings 2024-01-31 08365466 core:PlantMachinery 2024-02-01 2025-01-31 08365466 core:PlantMachinery 2025-01-31 08365466 core:PlantMachinery 2023-02-01 2024-01-31 08365466 core:PlantMachinery 2024-01-31 08365466 core:FurnitureFittingsToolsEquipment 2024-02-01 2025-01-31 08365466 core:FurnitureFittingsToolsEquipment 2025-01-31 08365466 core:FurnitureFittingsToolsEquipment 2023-02-01 2024-01-31 08365466 core:FurnitureFittingsToolsEquipment 2024-01-31 08365466 core:OfficeEquipment 2024-02-01 2025-01-31 08365466 core:OfficeEquipment 2025-01-31 08365466 core:OfficeEquipment 2023-02-01 2024-01-31 08365466 core:OfficeEquipment 2024-01-31 08365466 core:Vehicles 2024-02-01 2025-01-31 08365466 core:Vehicles 2025-01-31 08365466 core:Vehicles 2023-02-01 2024-01-31 08365466 core:Vehicles 2024-01-31 08365466 core:NetGoodwill 2024-02-01 2025-01-31 08365466 core:NetGoodwill 2025-01-31 08365466 core:NetGoodwill 2023-02-01 2024-01-31 08365466 core:NetGoodwill 2024-01-31 08365466 core:IntangibleAssetsOtherThanGoodwill 2024-02-01 2025-01-31 08365466 core:IntangibleAssetsOtherThanGoodwill 2025-01-31 08365466 core:IntangibleAssetsOtherThanGoodwill 2023-02-01 2024-01-31 08365466 core:IntangibleAssetsOtherThanGoodwill 2024-01-31

# SICKLE CELL CHAMPIONS CIC

## Company limited by guarantee

## Company Registration Number:
08365466 (England and Wales)

## Unaudited statutory accounts for the year ended 31 January 2025

## Period of accounts

## Start date: 1 February 2024

## End date: 31 January 2025

# SICKLE CELL CHAMPIONS CIC

## Contents of the Financial Statements

for the Period Ended 31 January 2025

Directors report |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# SICKLE CELL CHAMPIONS CIC

Directors' report period ended 31 January 2025

The directors present their report with the financial statements of the company for the period ended 31 January 2025

Principal activities of the company

Sickle Cell Champions CIC remained in hiatus during the year ended 31st January 2025

Company policy on disabled employees

The CIC has an Equal Opportunities policy.

Directors

The director shown below has held office during the whole of the period from
1 February 2024 to 31 January 2025

ADEGBOLA, Folayemi

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
7 November 2025

And signed on behalf of the board by:
Name: ADEGBOLA, Folayemi
Status: Director

# SICKLE CELL CHAMPIONS CIC

## Balance sheet

As at 31 January 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 1 | 1
Total fixed assets: |  | 1 | 1
Current assets
Cash at bank and in hand: |  | 13 |
Total current assets: |  | 13
Creditors: amounts falling due within one year: | 4 | ( 164 ) | ( 79 )
Net current assets (liabilities): |  | (151) | (79)
Total assets less current liabilities: |  | (150) | ( 78)
Total net assets (liabilities): |  | (150) | (78)
Members' funds
Profit and loss account: |  | (150) | ( 78)
Total members' funds: |  | ( 150) | (78)

The notes form part of these financial statements

# SICKLE CELL CHAMPIONS CIC

## Balance sheet statements

For the year ending 31 January 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 7 November 2025
and signed on behalf of the board by:

Name: ADEGBOLA, Folayemi
Status: Director

The notes form part of these financial statements

# SICKLE CELL CHAMPIONS CIC

## Notes to the Financial Statements

for the Period Ended 31 January 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

  Tangible fixed assets depreciation policy

  Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life.

# SICKLE CELL CHAMPIONS CIC

## Notes to the Financial Statements

for the Period Ended 31 January 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# SICKLE CELL CHAMPIONS CIC

## Notes to the Financial Statements

for the Period Ended 31 January 2025

## 3. Tangible assets

| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total
--- | --- | --- | --- | --- | --- | ---
Cost | £ | £ | £ | £ | £ | £
At 1 February 2024 |  | 4,600 |  |  |  | 4,600
Additions |  |  |  |  |  |
Disposals |  |  |  |  |  |
Revaluations |  |  |  |  |  |
Transfers |  |  |  |  |  |
At 31 January 2025 |  | 4,600 |  |  |  | 4,600
Depreciation |  |  |  |  |  |
At 1 February 2024 |  | 4,599 |  |  |  | 4,599
Charge for year |  |  |  |  |  |
On disposals |  |  |  |  |  |
Other adjustments |  |  |  |  |  |
At 31 January 2025 |  | 4,599 |  |  |  | 4,599
Net book value |  |  |  |  |  |
At 31 January 2025 |  | 1 |  |  |  | 1
At 31 January 2024 |  | 1 |  |  |  | 1

# SICKLE CELL CHAMPIONS CIC

## Notes to the Financial Statements

for the Period Ended 31 January 2025

## 4. Creditors: amounts falling due within one year note

| 2025 | 2024
--- | --- | ---
| £ | £
Other creditors | 164 | 79
Total | 164 | 79

# COMMUNITY INTEREST ANNUAL REPORT

### SICKLE CELL CHAMPIONS CIC

### Company Number: 08365466 (England and Wales)

### Year Ending: 31 January 2025

Company activities and impact

Sickle Cell Champions CIC remained in hiatus during the year ended 31st January 2025. It neither raised any funds nor carried out any events.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
6 November 2025

And signed on behalf of the board by:
Name: ADEGBOLA, Folayemi
Status: Director